Table 2:
Characteristics of hospitals treating stage 2 and 3 rectal cancer who received traditional therapy or Induction Chemotherapy (IC).
| Hospital Characteristics | Patients Receiving Treatment in Hospital Type/Location | ||
|---|---|---|---|
| Hospital Type | Traditional | IC | <0.001 |
| Community Cancer Program | 2,831 (9.0%) | 216 (7.1%) | |
| Comprehensive Community Cancer Program | 13,985 (44.5%) | 1,165 (38.4%) | |
| Academic/Research Program | 10,929 (34.8%) | 1,287 (42.4%) | |
| Integrate Network Cancer Program | 3,674 (11.7%) | 369 (12.2%) | |
| Hospital Region | <0.001 | ||
| New England | 1,775 (5.7%) | 206 (6.8%) | |
| Middle Atlantic | 4,000 (12.7%) | 564 (18.6%) | |
| South Atlantic | 6,811 (21.7%) | 639 (21.0%) | |
| East North Central | 6,462 (20.6%) | 547 (18.0%) | |
| East South Central | 1,914 (6.1%) | 222 (7.3%) | |
| West North Central | 3,342 (10.6%) | 181 (6.0%) | |
| West South Central | 2,338 (7.4%) | 255 (8.4%) | |
| Mountain | 1,508 (4.8%) | 110 (3.6%) | |
| Pacific | 3,269 (10.4%) | 313 (10.3%) | |